Browse > Home / Drugs / Watson Gets Positive Results With New Oxybutinin Topical Gel

Watson Gets Positive Results With New Oxybutinin Topical Gel

January 8, 2008

Phase 3 study results from its pivotal study of Oxybutynin Topical Gel for the treatment of overactive bladder appear promising.  

 “We are extremely encouraged with the results from this trial which will support our NDA submission, and we are on track to file with FDA in the second quarter of 2008,” said Paul Bisaro, Watson’s President and Chief Executive Officer. “Additionally, we have the potential to introduce the first gel formulation for the treatment of overactive bladder in 2009.”

Complete article found here.

Written by chris · Filed Under Drugs 

Comments

Got something to say?